United States, Rockville MD, Aug. 16, 2022 (GLOBE NEWSWIRE) -- As of 2022, the global blood gas and electrolyte analyzers market accounts for a revenue of US$ 4.2 billion and is expected to increase at a CAGR of 5.6% through 2030.
Increasing focus on healthcare across the world has resulted in a rise in medical tourism and this is anticipated to favor blood gas and electrolyte analyzers market potential over the years to come. Rising aging population, advancements in technology, and growing patient population in critical care establishments are other factors that will drive blood gas and electrolyte analyzers market growth.
For Critical Insights on Blood Gas and Electrolyte Analyzers Market, Request a Sample Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=5126
This new research by Fact.MR, a market research and competitive intelligence provider, has profiled prime players such as Radiometer Medical ApS., EKF Diagnostics, Abbott Point of Care Inc., ERBA Diagnostics Manheim GmbH, Alere Inc., Werfen, Erba Mannheim, Cornley Hi-tech Co. Ltd., EDAN Instruments Inc., F. Hoffman La Roche, and Fortress Diagnostics.
What’s Augmenting Blood Gas and Electrolyte Analyzers Market Growth?
“Rising Incidence of Diabetes & Blood Disorders across the World”
The prevalence of blood disorders and chronic illnesses has increased over the past few years and this trend is projected to be rife across the forecast period as well.
The aforementioned factors have resulted in high demand for blood testing and hence are expected to favor sales of blood gas and electrolyte analyzers over the next eight years.
Diabetes requires continuous blood monitoring and this is also anticipated to drive the blood gas and electrolyte analyzers market potential. The rising number of diagnostic procedures requiring blood analysis and testing are also projected to positively influence blood gas and electrolyte analyzers market potential through 2030.
To learn more about Blood Gas and Electrolyte Analyzers Market, you can get in touch with our Analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=5126
Key Segments Covered in the Blood Gas and Electrolyte Analyzers Industry Survey
- By Product Type :
- Electrolyte Analyzers
- Combined Analyzers
- Blood Gas Analyzers
- Consumables
- Electrolyte Analyzers
- By Modality :
- Portable
- Benchtop
- Laboratory
- Portable
- By End User :
- Point-of-care
- Diagnostic Centers
- Clinical Laboratories
- Other End Users
- Point-of-care
- By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
- North America
Competitive Landscape
Blood gas and electrolyte analyzer manufacturers are expected to focus on the development and launch of new advanced products to gain a competitive edge over other market players and strengthen their market presence.
- In July 2022, EDAN Instruments Inc., an organization dedicated to providing quality medical products, announced the launch of a new blood gas analysis system. i20 is a new POC (Point-of-Care) fluorescence-based CO-OX blood gas and chemistry analysis solution designed to relieve the burden from intensive care units (ICUs), operating rooms, etc.
Winning Strategy
Blood gas and electrolyte analyzers market players are expected to focus on advancing their research and development to fast-track the launch of new products. Manufacturers are also expected to focus on the integration of advanced technologies to enhance the efficiency of their product offerings.
Get Customization on Blood Gas and Electrolyte Analyzers Market Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=5126
Key players in the Blood Gas and Electrolyte Analyzers Market
- Siemens Healthcare
- Radiometer Medical ApS.
- EKF Diagnostics
- Cornley Hi-tech Co. Ltd.
- EDAN Instruments Inc.
- Abbott Point of Care Inc.
- ERBA Diagnostics Manheim GmbH
- Alere Inc.
Key Takeaways from Blood Gas and Electrolyte Analyzers Market Study
- Currently, the global blood gas and electrolyte analyzers market accounts for a valuation of US$ 4.2 billion.
- From 2022 to 2030, sales of blood gas and electrolyte analyzers are expected to rise at 5.6% CAGR.
- By 2030, the market is expected to be valued at US$ 6.5 billion.
- Increasing incidence of blood disorders, growing geriatric population, increasing investments in healthcare infrastructure development, and rising use of blood testing in various diagnostic procedures are factors propelling market growth.
- High costs of analyzers and complexity in the interpretation of blood analysis data are expected to have a hindering effect on overall market potential.
- The portable segment is anticipated to evolve at a CAGR of 5% throughout the forecast period.
Explore Fact.MR's Coverage on the Healthcare Domain-
Patient Positioning System Market- In 2020 the global patient positioning system market was valued at US$ 1 Bn and is expected to increase by nearly US$ 500 Mn by the end of 2031.
Dermatology Devices Market- Revenue from the global dermatology devices market reached US$ 12 Bn in 2020, and the market is predicted to reach US$ 39 Bn by 2031.
Medical Case Management Service Market- The global medical case management service market. The analysts have predicted the industry to expand at a stagnant CAGR of around 3.2% over the decade.
Over the Counter (OTC) Analgesics Market- The global OTC analgesics market was valued at around US$ 25 Bn in 2020, and is expected to accelerate at a CAGR of 5% through 2031. Demand for nonsteroidal anti-inflammatory drugs (NSAIDs) is set to increase at a CAGR of 4% across the assessment period of 2021 to 2031.
Hemostasis Diagnostics Market- As per the latest industry analysis on hemostasis diagnostics by Fact.MR, the global market was valued at around US$ 2 Bn in 2020, and is expected to accelerate at a CAGR of 7% to double in valuation and top US$ 4 Bn by 2031.
Liver Cancer Diagnostics Market- This revised research analysis on the liver cancer market by skilled analysts at Fact.MR predicts the industry to expand at a healthy CAGR of 8.2% over the next ten years.
Breathalyzer Market- The global breathalyzer market was valued at around US$ 760 Mn in 2020, which amounts to around 13% share of the overall drug testing market. Sales of breathalyzers are slated to accelerate at a steady CAGR of 8% to top US$ 1.7 Bn by 2031.
Spine Devices Market- Sales revenue from the global spine devices market was recorded at US$ 11 Bn in 2020, and is predicted to increase 1.5X by the end of the decade. These findings are from a revised analysis performed by Fact.MR, a market research and competitive intelligence provider.
Urinary Tract Infection Treatment Market- The global urinary tract infection treatment market was valued at US$ 10.5 Bn in 2021, and is expected to increase at a CAGR of 2.1% to reach US$ 12.9 Bn by 2031.
Flat Panel Detector Based X-Ray for Cone Beam CT Market- The global flat panel detector based X-Ray for cone beam CT (FPD-based X-Ray for CBCT) market is forecast to reach US$ 3.2 Bn in 2022, expected to surge at over 7% CAGR to reach US$ 6.3 Bn by the end of the 2022-2032 assessment period.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter
